Optimizing Treatment Strategies for Advanced Upper GI Cancers : Episode 9

Managing Symptoms and Quality of Life During HER2-Targeted Therapy for Upper GI Cancer

March 28, 2025

Opinion

Video

Experts discuss how to manage fatigue, abdominal pain, and other treatment-related symptoms to maintain or improve quality of life for patients undergoing HER2-targeted therapy and share strategies for supporting patients with declining performance status (eg, ECOG performance status [PS] 2) in balancing treatment efficacy with daily functioning.

EP: 1.Navigating Immune-Related Adverse Events With Nivolumab in Upper GI Cancer

EP: 2.Robert’s Journey With HER2- Upper GI Cancer

EP: 3.Strategies for Managing FOLFOX Toxicity in Upper GI Cancer

EP: 4.Supporting Patients Through Treatment for Upper GI Cancer Care

EP: 5.Communicating Treatment Adverse Effects: Strategies for Managing Expectations During Treatment for Upper GI Cancer

EP: 6.Balancing Treatment Intensity and Quality of Life in Upper GI Cancer

EP: 7.Megan’s Journey With HER2+ Upper GI Cancer

EP: 8.Managing Adverse Events With Trastuzumab Deruxtecan: Early Detection and ILD Monitoring Strategies

Now Viewing

EP: 9.Managing Symptoms and Quality of Life During HER2-Targeted Therapy for Upper GI Cancer

EP: 10.Multidisciplinary Collaboration in Managing Treatment-Related AEs in Upper GI Cancer

EP: 11.Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer Treatment

Video content above is prompted by the following:

• How do you manage fatigue, abdominal pain, and other treatment-related symptoms to maintain or improve quality of life for patients undergoing HER2-targeted therapy?
• What strategies do you use to support patients with declining performance status (eg, ECOG PS 2) in balancing treatment efficacy with daily functioning ?

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!